Literature DB >> 10202927

Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury.

T Sawa1, T L Yahr, M Ohara, K Kurahashi, M A Gropper, J P Wiener-Kronish, D W Frank.   

Abstract

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that can cause fatal acute lung infections in critically ill individuals. Damage to the lung epithelium is associated with the expression of toxins that are directly injected into eukaryotic cells through a type Ill-mediated secretion and translocation mechanism. Here we show that the P. aeruginosa homolog of the Yersinia V antigen, PcrV, is involved in the translocation of type III toxins. Vaccination against PcrV ensured the survival of challenged mice and decreased lung inflammation and injury. Antibodies to PcrV inhibited the translocation of type III toxins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202927     DOI: 10.1038/7391

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  131 in total

1.  Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.

Authors:  D Dacheux; I Attree; B Toussaint
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.

Authors:  I A Holder; A N Neely; D W Frank
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon.

Authors:  Denis Dacheux; Olivier Epaulard; Arjan de Groot; Benoit Guery; Rozen Leberre; Ina Attree; Benoit Polack; Bertrand Toussaint
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

4.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system.

Authors:  Leonard R Allmond; Timur J Karaca; Vinh N Nguyen; Thong Nguyen; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 6.  Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

7.  V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa.

Authors:  Leonard R Allmond; Temitayo Ajayi; Kiyoshi Moriyama; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 8.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

9.  Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas.

Authors:  Guy Schoehn; Anne Marie Di Guilmi; David Lemaire; Ina Attree; Winfried Weissenhorn; Andréa Dessen
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

10.  The ADP-ribosylating toxin, AexT, from Aeromonas salmonicida subsp. salmonicida is translocated via a type III secretion pathway.

Authors:  Sarah E Burr; Katja Stuber; Joachim Frey
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.